Search Results - "Ceejay L. Boyce"

Development and Optimization of Oligonucleotide Ligation Assay (OLA) Probes for Detection of HIV-1 Resistance to Dolutegravir by Beck, Ingrid A, Boyce, Ceejay L, Bishop, Marley D, Vu, Yen L, Fung, Amanda, Styrchak, Sheila, Panpradist, Nuttada, Lutz, Barry R, Frenkel, Lisa M

“…The WHO currently recommends dolutegravir (DTG)-based ART for persons living with HIV infection in resource-limited-settings (RLS). To expand access to testing…”
Get full text

Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term by Boyce, Ceejay L, Beck, Ingrid A, Styrchak, Sheila M, Hardy, Samantha R, Wallner, Jackson J, Milne, Ross S, Morrison, R Leavitt, Shapiro, David E, João, Esaú C, Mirochnick, Mark H, Frenkel, Lisa M

“…To assess in ART-naïve pregnant women randomized to efavirenz- versus raltegravir-based ART (IMPAACT P1081) whether pretreatment drug resistance (PDR) with…”
Get full text

The role of HIV biology in defining virological failure by Boyce, Ceejay L, Frenkel, Lisa M

Get full text

Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants by Boyce, Ceejay L, Sils, Tatiana, Ko, Daisy, Wong-on-Wing, Annie, Beck, Ingrid A, Styrchak, Sheila M, DeMarrais, Patricia, Tierney, Camlin, Stranix-Chibanda, Lynda, Flynn, Patricia M, Taha, Taha E, Owor, Maxensia, Fowler, Mary Glenn, Frenkel, Lisa M

“…Abstract Background We aimed to assess if maternal human immunodeficiency virus (HIV) drug resistance is associated with an increased risk of HIV vertical…”
Get full text

Brief Report: Characterizing HIV Drug Resistance in Cases of Vertical Transmission in the VESTED Randomized Antiretroviral Treatment Trial by Bishop, Marley D., Korutaro, Violet, Boyce, Ceejay L., Beck, Ingrid A., Styrchak, Sheila M., Knowles, Kevin, Ziemba, Lauren, Brummel, Sean S., Coletti, Anne, Jean-Philippe, Patrick, Chakhtoura, Nahida, Vhembo, Tichaona, Cassim, Haseena, Owor, Maxensia, Fairlie, Lee, Moyo, Sikhulile, Chinula, Lameck, Lockman, Shahin, Frenkel, Lisa M.

“…Introduction:VESTED (Virologic Efficacy and Safety of ART combinations with tenofovir alafenamide fumarate (TAF)/tenofovir disoproxil fumarate (TDF),…”
Get full text

HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients by Archampong, Timothy Na, Boyce, Ceejay L, Lartey, Margaret, Sagoe, Kwamena W, Obo-Akwa, Adjoa, Kenu, Ernest, Blackard, Jason T, Kwara, Awewura

“…The presence of HBV resistance mutations upon initiation or during antiretroviral therapy (ART) in HIV-coinfected patients is an important determinant of…”
Get more information

Hepatitis E Infection in a Longitudinal Cohort of Hepatitis C Virus and HCV/HIV Coinfected Persons by Sherman, Kenneth E, Kottilil, Shyam, Rouster, Susan D, Abdel-Hameed, Enass A, Boyce, Ceejay L, Meeds, Heidi L, Terrault, Norah, Shata, M Tarek

“…Hepatitis E virus (HEV) is thought to be common in the United States with increased prevalence in those with concomitant hepatitis C virus (HCV) or HCV/HIV…”
Get more information

Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans by Powell, Eleanor A, Boyce, Ceejay L, Gededzha, Maemu P, Selabe, Selokela G, Mphahlele, M Jeffrey, Blackard, Jason T

“…Occult hepatitis B is defined by the presence of hepatitis B virus (HBV) DNA in the absence of hepatitis B surface antigen (HBsAg). Occult HBV is associated…”
Get full text

Ultra-Deep Genomic Sequencing of HCV NS5A Resistance-Associated Substitutions in HCV/HIV Coinfected Patients by Abdel-hameed, Enass A., Rouster, Susan D., Boyce, Ceejay L., Zhang, Xiang, Biesiada, Jacek, Medvedovic, Mario, Sherman, Kenneth E.

“…Background and Aims The prevalence of naturally occurring HCV-NS5A resistance-associated substitutions (RAS) to DAA drugs might affect the response to…”
Get full text

Identification of hepatitis B virus genotype A/E recombinants in Ghana by Boyce, Ceejay L., Willis, Stephaney, Archampong, Timothy N. A., Lartey, Margaret, Sagoe, Kwamena W., Obo-Akwa, Adjoa, Kenu, Ernest, Kwara, Awewura, Blackard, Jason T.

“…Hepatitis B virus (HBV) exhibits a high degree of heterogeneity with at least 10 genotypes (A–J) identified to date. Intergenotypic recombination is relatively…”
Get full text

Identification and comparative analysis of hepatitis B virus genotype D/E recombinants in Africa by Boyce, Ceejay L., Ganova-Raeva, Lilia, Archampong, Timothy N. A., Lartey, Margaret, Sagoe, Kwamena W., Obo-Akwa, Adjoa, Kenu, Ernest, Kwara, Awewura, Blackard, Jason T.

“…Globally, there are approximately 240 million people chronically infected with hepatitis B virus (HBV)—a major cause of hepatocellular carcinoma. Ten different…”
Get full text

Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term by Ceejay L. Boyce, Ingrid A. Beck, Sheila M. Styrchak, Samantha R. Hardy, Jackson J. Wallner, Ross S. Milne, R. Leavitt Morrison, David E. Shapiro, Esaú C. João, Mark H. Mirochnick, Lisa M. Frenkel

“…Objective To assess in ART-naïve pregnant women randomized to efavirenz- versus raltegravir-based ART (IMPAACT P1081) whether pretreatment drug resistance…”
Get full text

Characterizing HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial by Bishop, Marley D, Korutaro, Violet, Boyce, Ceejay L, Beck, Ingrid A, Styrchak, Sheila M, Knowles, Kevin, Ziemba, Lauren, Brummel, Sean S, Coletti, Anne, Jean-Philippe, Patrick, Chakhtoura, Nahida, Vhembo, Tichaona, Cassim, Haseena, Owor, Maxensia, Fairlie, Lee, Moyo, Sikhulile, Chinula, Lameck, Lockman, Shahin, Frenkel, Lisa M

“…VESTED (NCT03048422) compared the safety and efficacy of three antiretroviral treatment ( ) regimens in pregnant and postpartum women:…”
Get full text